share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Echevarria Joseph

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Echevarria Joseph

輝瑞 | 4:持股變動聲明-董事 Echevarria Joseph
美股sec公告 ·  04/26 13:24
Moomoo AI 已提取核心訊息
Joseph Echevarria, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Echevarria to Pfizer has not been specified, and there is no information provided on the number of shares held after the action.
Joseph Echevarria, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Echevarria to Pfizer has not been specified, and there is no information provided on the number of shares held after the action.
輝瑞公司 [PFE] 的舉報人約瑟夫·埃切瓦里亞於2024年4月25日參與了一筆交易。公告中沒有披露有關交易性質的具體細節,包括股票數量、交易價格和股票總價值。Echevarria與輝瑞的關係尚未具體說明,也沒有提供有關行動後持有的股票數量的信息。
輝瑞公司 [PFE] 的舉報人約瑟夫·埃切瓦里亞於2024年4月25日參與了一筆交易。公告中沒有披露有關交易性質的具體細節,包括股票數量、交易價格和股票總價值。Echevarria與輝瑞的關係尚未具體說明,也沒有提供有關行動後持有的股票數量的信息。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息